MABPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2024
MABPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024
MABPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024
MABPHARM-B: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
MABPHARM-B: (1) APPOINTMENT OF NON-EXECUTIVE DIRECTOR ANDINDEPENDENT NON-EXECUTIVE DIRECTOR(2) RE-DESIGNATION OF NON-EXECUTIVE DIRECTORAND(3) APPOINTMENT OF VICE PRESIDENTS
MABPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024
MABPHARM-B: INSIDE INFORMATION ANNOUNCEMENTAPPROVAL FROM THE MINISTRY OF HEALTH OF PERUON THE NEW DRUG APPLICATION (NDA)OF OUR CORE PRODUCT, CMAB008 (INFLIXIMAB FOR INJECTION)
MABPHARM-B: INSIDE INFORMATION ANNOUNCEMENTAPPROVAL FROM THE NATIONAL MEDICAL PRODUCTSADMINISTRATION ON THE NEW DRUG APPLICATION (NDA)OF OUR CORE PRODUCT, CMAB009 (CETUXIMAB BETA INJECTION)
MABPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024
MABPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024
MABPHARM-B: FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, JUNE 21, 2024
MABPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
MABPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
MABPHARM-B: Notification Letter and Reply Form to Non-registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications
MABPHARM-B: Notification Letter and Reply Form to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications
MABPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
MABPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
MABPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023
MABPHARM-B: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
MABPHARM-B: (1) RESIGNATION OF EXECUTIVE DIRECTOR AND NON-EXECUTIVE DIRECTOR (2) APPOINTMENT OF EXECUTIVE DIRECTOR AND NON-EXECUTIVE DIRECTOR
No Data
No Data